Product Wiki · Recalls · EU Safety Gate (RAPEX)

Sport Toys — Toys — recall SR/01002/25

EU Safety Gate (RAPEX) · Sweden · 2025-03-21 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01002/25
Date of alert
2025-03-21
Country / jurisdiction
Sweden
Risk level
Serious risk
Risk type
Chemical
Brand
Sport Toys
Product category
Toys
Product type
Plastic ball
Barcode (EAN/GTIN)
7392870174527
Reported risk: The migration of lead from the toy is too high (measured value: 0.35 % by weight). Lead is harmful to children as it can lead to developmental neurotoxicity. It accumulates in the body and may also affect their future progeny when breast-fed or unborn. Moreover, the plastic material of the plastic balls has an excessive concentration of bis(2-ethylhexyl) phthalate (DEHP)(measured values: 7.6 % by weight). DEHP may harm the health by causing possible damage to the reproductive system.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Retailer
Category of measure
Withdrawal of the product from the market
Date of entry into force
10/09/2024
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10093262

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.